Literature DB >> 10215071

Prenatal diagnosis and elective termination of Down syndrome in a racially mixed population in Hawaii, 1987-1996.

M B Forrester1, R D Merz.   

Abstract

The impact of demographic factors on the prenatal diagnosis and elective termination of Down syndrome in Hawaii between 1987 and 1996 were examined. Data were obtained from a population-based birth defects registry and included 306 Down syndrome cases. 131 (43 per cent) of the cases were prenatally diagnosed. Of the prenatally diagnosed cases, 110(84 per cent) were electively terminated. Advanced maternal age or having a maternal serum alpha-fetoprotein screen performed increased the probability of having an affected pregnancy prenatally diagnosed and electively terminated. Far East Asians were substantially more likely to have an affected pregnancy prenatally diagnosed and electively terminated. Pacific Islanders and Filipinos were less likely to have cases prenatally diagnosed and electively terminated. Prenatally diagnosed and electively terminated Down syndrome cases had disproportionately fewer additional birth defects than live births or fetal demises, suggesting that for many of the electively terminated cases additional birth defects may not have been identified. This implies that the elective termination of Down syndrome-affected pregnancies may influence not only the Down syndrome prevalence but also that of other birth defects.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Substances:

Year:  1999        PMID: 10215071

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  9 in total

1.  Socially repugnant or the standard of care: Is there a distinction between sex-selective and ability-selective abortion?

Authors:  Rebecca Lobo; Garnett Genuis
Journal:  Can Fam Physician       Date:  2014-03       Impact factor: 3.275

2.  A Framework for the Development of maternal quality of care indicators.

Authors:  Lisa M Korst; Kimberly D Gregory; Michael C Lu; Carolina Reyes; Calvin J Hobel; Gilberto F Chavez
Journal:  Matern Child Health J       Date:  2005-09

3.  Is the prevalence of Down syndrome births in Hawai'i increasing?

Authors:  Heather McDermott; Jean L Johnson
Journal:  Hawaii Med J       Date:  2011-04

4.  Attitudes of Filipino parents of children with Down syndrome on noninvasive prenatal testing.

Authors:  Leniza G de Castro-Hamoy; Ma-Am Joy R Tumulak; Maria Stephanie Fay S Cagayan; Peter A Sy; Nona Rachel C Mira; Mercy Y Laurino
Journal:  J Community Genet       Date:  2022-06-02

5.  What do patients prefer: informed consent models for genetic carrier testing.

Authors:  K E Ormond; M Iris; S Banuvar; J Minogue; G J Annas; S Elias
Journal:  J Genet Couns       Date:  2007-05-11       Impact factor: 2.537

6.  Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions.

Authors:  Cara T Mai; James E Kucik; Jennifer Isenburg; Marcia L Feldkamp; Lisa K Marengo; Erin M Bugenske; Phoebe G Thorpe; Jodi M Jackson; Adolfo Correa; Russel Rickard; C J Alverson; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-11

7.  Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.

Authors:  Jodi M Jackson; Krista S Crider; Janet D Cragan; Sonja A Rasmussen; Richard S Olney
Journal:  Am J Med Genet A       Date:  2013-11-22       Impact factor: 2.802

8.  Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development.

Authors:  Evelyne E Muggli; David McCloskey; Jane L Halliday
Journal:  BMC Health Serv Res       Date:  2006-09-01       Impact factor: 2.655

9.  A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.

Authors:  Brandon S Walker; Richard E Nelson; Brian R Jackson; David G Grenache; Edward R Ashwood; Robert L Schmidt
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.